Abstract
Improved Specificity for Breast Cancer Screening Using an Oncogenic (miRNA-21) and a Gene Suppressor (miRNA-195) miRNA in the Serum for a Point of Care (POC) Screening Solution
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have